Gabriella Ferlazzo
Overview
Explore the profile of Gabriella Ferlazzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guglielmetti L, Khan U, Velasquez G, Gouillou M, Abubakirov A, Baudin E, et al.
N Engl J Med
. 2025 Jan;
392(5):468-482.
PMID: 39879593
Background: For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now permit randomized,...
2.
Das M, Mathur T, Ravi S, Meneguim A, Iyer A, Mansoor H, et al.
PLoS One
. 2024 Feb;
19(2):e0299482.
PMID: 38381772
[This corrects the article DOI: 10.1371/journal.pone.0248408.].
3.
Chavan V, Dalal A, Nagaraja S, Thekkur P, Mansoor H, Meneguim A, et al.
PLoS One
. 2024 Feb;
19(2):e0299477.
PMID: 38381762
[This corrects the article DOI: 10.1371/journal.pone.0234651.].
4.
Laxmeshwar C, Das M, Mathur T, Israni T, Jha S, Iyer A, et al.
PLoS One
. 2024 Jan;
19(1):e0298137.
PMID: 38285710
[This corrects the article DOI: 10.1371/journal.pone.0263759.].
5.
Tesfahun H, Al-Salihi L, Abdulkareem Al-Ani N, Mankhi A, Mohammed A, Lim C, et al.
PLoS One
. 2024 Jan;
19(1):e0296952.
PMID: 38241233
Since December 2019, the World Health Organization (WHO) has encouraged National Tuberculosis Programs to deprioritize the use of injectable-containing regimens and roll-out all-oral bedaquiline-containing regimens for rifampicin-resistant tuberculosis (RR-TB) treatment....
6.
Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc F, et al.
Lancet Glob Health
. 2023 May;
11(6):e903-e916.
PMID: 37202025
Background: Sputum is the most widely used sample to diagnose active tuberculosis, but many people living with HIV are unable to produce sputum. Urine, in contrast, is readily available. We...
7.
Chiang S, Waterous P, Atieno V, Bernays S, Bondarenko Y, Cruz A, et al.
J Adolesc Health
. 2023 Feb;
72(3):323-331.
PMID: 36803849
No abstract available.
8.
Huerga H, Bastard M, Lubega A, Akinyi M, Antabak N, Ohler L, et al.
Lancet Glob Health
. 2022 Dec;
11(1):e126-e135.
PMID: 36521944
Background: Development of rapid biomarker-based tests that can diagnose tuberculosis using non-sputum samples is a priority for tuberculosis control. We aimed to compare the diagnostic accuracy of the novel Fujifilm...
9.
Laxmeshwar C, Das M, Mathur T, Israni T, Jha S, Iyer A, et al.
PLoS One
. 2022 Feb;
17(2):e0263759.
PMID: 35148328
Background: People with drug-resistant tuberculosis (DR-TB) are known to suffer from many mental-health disorders. This study aims to describe the proportion of patients diagnosed with psychiatric comorbidities, the different psychiatric...
10.
Das M, Mathur T, Ravi S, Meneguim A, Iyer A, Mansoor H, et al.
PLoS One
. 2021 Mar;
16(3):e0248408.
PMID: 33690715
Background: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in children are better than adults,...